Novogate Medical

Apical Closure Device

Health Tech & Life Sciences
Non Active, Jan 2021 ceased to operate
Pre-Funding Caesarea, Israel Founded 2011
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2011
Headcount
1-10
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

Novogate Medical is the developer of Wisefix, a minimally invasive trans-apical access and closure system. The Wisefix system addresses two critical areas in the percutaneous valve implantation field: transcatheter aortic valve repair implantation and transcatheter mitral valve repair/replacement.

Q&A

What is Novogate Medical's primary product?
Novogate Medical developed Wisefix, a minimally invasive trans-apical access and closure system designed for percutaneous valve implantation procedures.
What medical conditions does Novogate Medical's technology address?
The Wisefix system addresses critical areas in transcatheter aortic valve repair implantation and transcatheter mitral valve repair/replacement.
When was Novogate Medical founded?
Novogate Medical was founded in January 2011.
What is the current status of Novogate Medical?
Novogate Medical is currently inactive and ceased to operate in January 2021.
Where is Novogate Medical headquartered?
Novogate Medical is headquartered in Caesarea, Israel.
What is Novogate Medical's employee count range?
Novogate Medical has an employee bucket range of 1-10 employees.
What is Novogate Medical's primary sector?
Novogate Medical's primary sector is Health Tech & Life Sciences.
Does Novogate Medical hold any patents?
Yes, Novogate Medical holds 1 patent.

Team · 1

Founder · Founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

cardiologymedical-devicesheart-diseasessurgeonssurgeryminimally-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)